Ad
related to: bmy latest newssuperstockscreener.com has been visited by 10K+ users in the past month
Search results
Results from the WOW.Com Content Network
The lack of a warning sent Bristol Myers' shares up 6.3% at $53.28 in premarket trading on Friday. Bristol Myers obtained drug Cobenfy, also known as KarXT, through its $14 billion takeover of ...
Biopharmaceutical giant Bristol Myers Squibb (NYSE:BMY) reported fourth-quarter and full-year 2024 earnings on Thursday, Feb. 6, that topped analysts' consensus estimates. Adjusted earnings per ...
In the latest trading session, Bristol Myers Squibb (BMY) closed at $71.71, marking a -0.49% move from the previous day.
Bristol-Myers Squibb (BMY) closed at $60.50 in the latest trading session, marking a -1.59% move from the prior day.
Two of these, Bristol Myers Squibb (NYSE: BMY) and Eli Lilly (NYSE: LLY), just declared dividend raises. What's more, since the new payouts will represent the two companies' first dividends of ...
In the latest trading session, Bristol Myers Squibb (BMY) closed at $64.82, marking a -1.01% move from the previous day.
How did Humira get to be the best-selling drug of all time, and why should Bristol-Myers' new candidate dare at all compare? ... News. Search. Need help? Call us! 800-290-4726. Login / Join. Mail.
In the latest trading session, Bristol Myers Squibb (BMY) closed at $59.51, marking a +0.78% move from the previous day. Skip to main content. 24/7 Help. For premium support please call: 800-290 ...
Ad
related to: bmy latest newssuperstockscreener.com has been visited by 10K+ users in the past month